SEQUENOM Secures Rights to Key Non-Invasive Prenatal Diagnostic Intellectual Property
24-Oct-2005 -
SEQUENOM, Inc. has acquired exclusive rights in certain countries including the United States, United Kingdom and other countries in Europe and elsewhere, to non-invasive prenatal diagnostic intellectual property from Isis Innovation Ltd., the technology transfer company of the University of ...
acids
anemia
cystic fibrosis
+7